+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Infertility Drugs & Devices Market Report 2024-2034

  • PDF Icon

    Report

  • 351 Pages
  • June 2024
  • Region: Global
  • Visiongain
  • ID: 5979699
Overall world revenue for Infertility Drugs & Devices Market, 2024 to 2034 in terms of value the market will surpass US$5.9 billion in 2024, the work calculates. The publisher predicts strong revenue growth through to 2034. The work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

The Infertility Drugs & Devices Market Report 2024-2034: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

High cost of treatment

A single IVF cycle ranges from US$15,000 to US$30,000, depending on the centre and the patient needs. Medications constitute 35% of these charges and other additional costs such as genetic testing of the embryos and surgical procedures that increases the cost further. Also, the costs would also depend on number of cycles conducted that range from 1 to 6, which imposes heavy financial burden on the patients. Such high costs limit the use and appropriate treatment option for the patients restricting market growth. Whereas the insurance coverage especially in the U.S. depends on the coverage plans that the employer has offered. Semen analysis is usually covered. However, major parts of the treatment such as embryo transfer, mini-IVF costs, Full IVF cost, using donor egg costs are not completely covered under insurance. There is a growing demand from employers in the U.S. to also provide fertility treatment coverage.

Unsupportive Government Regulations

Government regulations in the form of funding, grants, policies, subsidies, insurance greatly impact the adoption of ART procedures. Lack of these support systems the access to treatment services is restricted and hence leads to limited adoption of these clinical services. For instance, in Japan, ART treatments were initiated to be covered under health insurance since April 2022 as a move to deal with low fertility rates. Prior to this, only eligible couples received partial subsidies for ART treatment due to focus on lower-income citizens in Japan. Similar norms were set up for ART subsidies in Korea and Taiwan. In the U.S., only 15 states have authorized legislation to private insurers to cover partial or full costs of infertility treatments, however, type of coverage varies by state, with only 8 states authorizing reimbursement for ART. Most European countries allow gametes donation that includes eggs and sperms. Sperm donation is allowed in 20 EU states while Egg donation is permitted in 17 states of the total 27 EU states. These regulations limit the adoption of ART and hence act as a critical barrier in market growth.

Key Questions Answered

  • How is the Infertility Drugs & Devices market evolving?
  • What is driving and restraining the Infertility Drugs & Devices market?
  • How will each Infertility Drugs & Devices submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
  • How will the market shares for each Infertility Drugs & Devices submarket develop from 2024 to 2034?
  • What will be the main driver for the overall market from 2024 to 2034?
  • Will leading Infertility Drugs & Devices markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
  • Who are the leading players and what are their prospects over the forecast period?
  • What are the Infertility Drugs & Devices projects for these leading companies?
  • How will the industry evolve during the period between 2024 and 2034? What are the implications of Infertility Drugs & Devices projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the Infertility Drugs & Devices market?
  • Where is the Infertility Drugs & Devices market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Infertility Drugs & Devices market today, and over the next 10 years:

  • This 351-page report provides 156 tables and 245 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them - NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

Forecasts to 2034 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2034, the new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Infertility Drugs & Devices prices and recent developments.

Segments Covered in the Report

Product

  • Drugs
  • Gonadotropins
  • Aromatase Inhibitors
  • Selective Estrogen Receptor Modulators (SERMs)
  • Dopamine Agonists
  • Other drug classes
  • Equipment
  • Microscopes
  • Imaging Systems
  • Sperm Analyzer Systems
  • Ovum Aspiration Pumps
  • Micromanipulator Systems
  • Incubators
  • Gas Analyzers
  • Laser Systems
  • Cryosystems
  • Sperm Separation Devices
  • Media & Consumables
  • Accessories

Procedure

  • Assisted Reproductive Technology
  • IVF
  • Intracytoplasmic Sperm Injection
  • Surrogacy
  • Artificial Insemination
  • Intrauterine
  • Intracervical
  • Intratubal
  • Fertility Surgeries
  • Laparoscopy
  • Hysteroscopy
  • Varicocelectomy
  • Laparotomy
  • Tubal Ligation Reversal
  • Microsurgical Reconstruction
  • Other Infertility Treatment Procedures

Patient

  • Female
  • Male

End-Use

  • Fertility Centers
  • Hospitals & Surgical Clinics
  • Cryobanks
  • Research Institutes
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 16 leading national markets:

North America

  • U.S.
  • Canada

Europe

  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Mexico
  • Rest of Latin America

MEA

  • GCC
  • South Africa
  • Rest of MEA
The report also includes profiles and for some of the leading companies in the Infertility Drugs & Devices Market, 2024 to 2034, with a focus on this segment of these companies’ operations.

Leading companies profiled in the report

  • Abbott Laboratories
  • Esco Micro Pte Ltd
  • Ferring BV
  • FUJIFILM Irvine Scientific
  • Hamilton Thorne
  • Merck KGaA
  • The Baker Company
  • The Cooper Companies, Inc.
  • Thermo Fisher Scientific
  • Vitrolife

How will the Infertility Drugs & Devices Market, 2024 to 2034 report help you?

In summary, the 350+ page report provides you with the following knowledge:
  • Revenue forecasts to 2034 for Infertility Drugs & Devices Market, 2024 to 2034 Market, with forecasts for product, procedure, patient, end-use, each forecast at a global and regional level - discover the industry’s prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2034 for five regional and 16 key national markets - See forecasts for the Infertility Drugs & Devices Market, 2024 to 2034 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the U.S., Canada, Mexico, Brazil, Germany, France, U.K., Italy, China, India, Japan, and Australia among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 10 of the major companies involved in the Infertility Drugs & Devices Market, 2024 to 2034.
Find quantitative and qualitative analyses with independent predictions. Receive information that only this report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With this new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how this work could benefit your research, analyses, and decisions. This study is for everybody needing commercial analyses for the Infertility Drugs & Devices Market, 2024 to 2034, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview
1.1 Objectives of the Study
1.2 Introduction to Infertility Drugs & Devices Market
1.3 What This Report Delivers
1.4 Why You Should Read This Report
1.5 Key Questions Answered by This Analytical Report Include:
1.6 Who is This Report For?
1.7 Methodology
1.7.1 Market Definitions
1.7.2 Market Evaluation & Forecasting Methodology
1.7.3 Data Validation
1.8 Frequently Asked Questions (FAQs)
1.9 Associated Reports
1.10 About the Publisher
2 Executive Summary
3 Market Overview
3.1 Key Findings
3.2 Market Dynamics
3.3 Impact Analysis
3.3.1 Market Driving Factors
3.3.2 Market Restraining Factors
3.3.3 Market Opportunities
3.4 Supply Chain Analysis
3.5 Regulatory Framework
3.6 Emerging Markets and Megatrends
3.7 Porter’s Five Forces Analysis
3.7.1 Supplier Power
3.7.2 Buyer Power
3.7.3 Competitive Rivalry
3.7.4 Threat of Substitutes
3.7.5 Threat of New Entrants
3.8 PEST Analysis
4 Global Infertility Drugs & Devices Market Analysis by Product
4.1 Key Findings
4.2 Product Segment: Market Attractiveness Index
4.3 Infertility Drugs & Devices Market Size Estimation and Forecast by Product
4.4 Drugs
4.4.1 Drugs Market Forecast by Region, 2024-2034 (US$ Mn)
4.4.2 Drugs Market Share by Region, 2024 and 2034 (%)
4.4.3 Drugs Market Forecast by Type, 2024-2034 (US$ Mn)
4.4.4 Drugs Market Share by Type, 2024 and 2034 (%)
4.5 Equipment
4.5.1 Equipment Market Forecast by Region, 2024-2034 (US$ Mn)
4.5.2 Equipment Market Share by Region, 2024 and 2034 (%)
4.5.3 Equipment Market Forecast by Type, 2024-2034 (US$ Mn)
4.5.4 Equipment Market Share by Type, 2024 and 2034 (%)
4.6 Media & Consumables
4.6.1 Media & Consumables Market Forecast, 2024-2034 (US$ Mn)
4.6.2 Media & Consumables Market Share by Region, 2024 and 2034 (%)
4.7 Accessories
4.7.1 Accessories Market Forecast by Region, 2024-2034 (US$ Mn)
4.7.2 Accessories Market Share by Region, 2024 and 2034 (%)
5 Infertility Drugs & Devices Market Analysis by Procedure
5.1 Key Findings
5.2 Procedure Segment: Market Attractiveness Index
5.3 Infertility Drugs & Devices Market Size Estimation and Forecast by Procedure
5.4 Infertility Drugs & Devices Market Share by Procedure, 2024 & 2034
5.5 Assisted Reproductive Technology
5.5.1 Assisted Reproductive Technology Market Forecast by Region, 2024-2034 (US$ Mn)
5.5.2 Assisted Reproductive Technology Market Share by Region, 2024 and 2034 (%)
5.5.3 Assisted Reproductive Technology Market Forecast by Type, 2024-2034 (US$ Mn)
5.5.4 Assisted Reproductive Technology Market Share by Type, 2024 and 2034 (%)
5.6 Artificial Insemination
5.6.1 Artificial Insemination Market Forecast, 2024-2034 (US$ Mn)
5.6.2 Artificial Insemination Market Share by Region, 2024 and 2034 (%)
5.6.3 Artificial Insemination Market Forecast by Type, 2024-2034 (US$ Mn)
5.6.4 Artificial Insemination Market Share by Type, 2024 and 2034 (%)
5.7 Fertility Surgeries
5.7.1 Fertility Surgeries Market Forecast by Region, 2024-2034 (US$ Mn)
5.7.2 Fertility Surgeries Market Share by Region, 2024 and 2034 (%)
5.7.3 Fertility Surgeries Market Forecast by Type, 2024-2034 (US$ Mn)
5.7.4 Fertility Surgeries Market Share by Type, 2024 and 2034 (%)
5.8 Other Infertility Treatment Procedures
5.8.1 Other Infertility Treatment Procedures Market Forecast by Region, 2024-2034 (US$ Mn)
5.8.2 Other Infertility Treatment Procedures Market Share by Region, 2024 and 2034 (%)
6 Infertility Drugs & Devices Market Analysis by Patient
6.1 Key Findings
6.2 Patient Segment: Market Attractiveness Index
6.3 Infertility Drugs & Devices Market Size Estimation and Forecast by Patient
6.4 Infertility Drugs & Devices Market Share by Patient, 2024, 2029, 2034
6.5 Female
6.5.1 Female Market Forecast by Region, 2024-2034 (US$ Mn)
6.5.2 Female Market Share by Region, 2024 and 2034 (%)
6.6 Male
6.6.1 Male Market Forecast by Region, 2024-2034 (US$ Mn)
6.6.2 Male Market Share by Region, 2024 and 2034 (%)
7 Infertility Drugs & Devices Market Analysis by End-use
7.1 Key Findings
7.2 End-use Segment: Market Attractiveness Index
7.3 Infertility Drugs & Devices Market Size Estimation and Forecast by End-use
7.4 Infertility Drugs & Devices Market Share by End-use, 2024, 2029, 2034
7.5 Fertility Centers
7.5.1 Fertility Centers Market Forecast by Region, 2024-2034 (US$ Mn)
7.5.2 Fertility Centers Market Share by Region, 2024 and 2034 (%)
7.6 Hospitals & Surgical Clinics
7.6.1 Hospitals & Surgical Clinics Market Forecast by Region, 2024-2034 (US$ Mn)
7.6.2 Hospitals & Surgical Clinics Market Share by Region, 2024 and 2034 (%)
7.7 Cryobanks
7.7.1 Cryobanks Market Forecast by Region, 2024-2034 (US$ Mn)
7.7.2 Cryobanks Market Share by Region, 2024 and 2034 (%)
7.8 Research Institutes
7.8.1 Research Institutes Market Forecast by Region, 2024-2034 (US$ Mn)
7.8.2 Research Institutes Market Share by Region, 2024 and 2034 (%)
8 Infertility Drugs & Devices Market Analysis by Region
8.1 Key Findings
8.2 Regional Market Size Estimation and Forecast
9 North America Infertility Drugs & Devices Market Analysis
9.1 Key Findings
9.2 North America Infertility Drugs & Devices Market Attractiveness Index
9.3 North America Infertility Drugs & Devices Market by Country, 2024, 2029 & 2034 (US$ Mn)
9.4 North America Infertility Drugs & Devices Market Size Estimation and Forecast by Country
9.5 North America Infertility Drugs & Devices Market Size Estimation and Forecast by Product
9.6 North America Infertility Drugs & Devices Market Size Estimation and Forecast by Drugs
9.7 North America Infertility Drugs & Devices Market Size Estimation and Forecast by Equipment
9.8 North America Infertility Drugs & Devices Market Size Estimation and Forecast by Procedure
9.9 North America Infertility Drugs & Devices Market Size Estimation and Forecast by Patient
9.10 North America Infertility Drugs & Devices Market Size Estimation and Forecast by End-users
9.11 U.S.
9.11.1 U.S. Infertility Drugs & Devices Market by Product
9.12 Canada
9.12.1 Canada Infertility Drugs & Devices Market by Product
10 Europe Infertility Drugs & Devices Market Analysis
10.1 Key Findings
10.2 Europe Infertility Drugs & Devices Market Attractiveness Index
10.3 Europe Infertility Drugs & Devices Market by Country, 2024, 2029 & 2034 (US$ Mn)
10.4 Europe Infertility Drugs & Devices Market Size Estimation and Forecast by Country
10.5 Europe Infertility Drugs & Devices Market Size Estimation and Forecast by Product
10.6 Europe Infertility Drugs & Devices Market Size Estimation and Forecast by Drugs
10.7 Europe Infertility Drugs & Devices Market Size Estimation and Forecast by Equipment
10.8 Europe Infertility Drugs & Devices Market Size Estimation and Forecast by Procedure
10.9 Europe Infertility Drugs & Devices Market Size Estimation and Forecast by Patient
10.10 Europe Infertility Drugs & Devices Market Size Estimation and Forecast by End-use
10.11 Germany
10.11.1 Germany Infertility Drugs & Devices Market by Product
10.12 U.K.
10.12.1 U.K. Infertility Drugs & Devices Market by Product
10.13 France
10.13.1 France Infertility Drugs & Devices Market by Product
10.14 Italy
10.14.1 Italy Infertility Drugs & Devices Market by Product
10.15 Spain
10.15.1 Spain Infertility Drugs & Devices Market by Product
10.16 Rest of Europe
10.16.1 Rest of Europe Infertility Drugs & Devices Market by Product
11 Asia Pacific Infertility Drugs & Devices Market Analysis
11.1 Key Findings
11.2 Asia Pacific Infertility Drugs & Devices Market Attractiveness Index
11.3 Asia Pacific Infertility Drugs & Devices Market by Country, 2024, 2029 & 2034 (US$ Mn)
11.4 Asia Pacific Infertility Drugs & Devices Market Size Estimation and Forecast by Country
11.5 Asia Pacific Infertility Drugs & Devices Market Size Estimation and Forecast by Product
11.6 Asia Pacific Infertility Drugs & Devices Market Size Estimation and Forecast by Drugs
11.7 Asia Pacific Infertility Drugs & Devices Market Size Estimation and Forecast by Equipment
11.8 Asia-Pacific Infertility Drugs & Devices Market Size Estimation and Forecast by Procedure
11.9 Asia Pacific Infertility Drugs & Devices Market Size Estimation and Forecast by Patient
11.10 Asia Pacific Infertility Drugs & Devices Market Size Estimation and Forecast by End-use
11.11 Japan
11.11.1 Japan Infertility Drugs & Devices Market by Product
11.12 China
11.12.1 China Infertility Drugs & Devices Market by Product
11.13 India
11.13.1 India Infertility Drugs & Devices Market by Product
11.14 South Korea
11.14.1 South Korea Infertility Drugs & Devices Market by Product
11.15 Australia
11.15.1 Australia Infertility Drugs & Devices Market by Product
11.16 Rest of APAC
11.16.1 Rest of APAC Infertility Drugs & Devices Market by Product
12 Latin America Infertility Drugs & Devices Market Analysis
12.1 Key Findings
12.2 Latin America Infertility Drugs & Devices Market Attractiveness Index
12.3 Latin America Infertility Drugs & Devices Market by Country, 2024, 2029 & 2034 (US$ Mn)
12.4 Latin America Infertility Drugs & Devices Market Size Estimation and Forecast by Country
12.5 Latin America Infertility Drugs & Devices Market Size Estimation and Forecast by Product
12.6 Latin America Infertility Drugs & Devices Market Size Estimation and Forecast by Drugs
12.7 Latin America Infertility Drugs & Devices Market Size Estimation and Forecast by Equipment
12.8 Latin America Infertility Drugs & Devices Market Size Estimation and Forecast by Procedure
12.9 Latin America Infertility Drugs & Devices Market Size Estimation and Forecast by Patient
12.10 Latin America Infertility Drugs & Devices Market Size Estimation and Forecast by End-use
12.11Brazil
12.11.1 Brazil Infertility Drugs & Devices Market by Product
12.12 Mexico
12.12.1 Mexico Infertility Drugs & Devices Market by Product
12.13 Rest of Latin America
12.13.1 Rest of LATAM Infertility Drugs & Devices Market by Product
13 MEA Infertility Drugs & Devices Market Analysis
13.1 Key Findings
13.2 MEA Infertility Drugs & Devices Market Attractiveness Index
13.3 MEA Infertility Drugs & Devices Market by Country, 2024, 2029 & 2034 (US$ Mn)
13.4 MEA Infertility Drugs & Devices Market Size Estimation and Forecast by Country
13.5 MEA Infertility Drugs & Devices Market Size Estimation and Forecast by Product
13.6 MEA Infertility Drugs & Devices Market Size Estimation and Forecast by Drugs
13.7 MEA Infertility Drugs & Devices Market Size Estimation and Forecast by Equipment
13.8 MEA Infertility Drugs & Devices Market Size Estimation and Forecast by Procedure
13.9 MEA Infertility Drugs & Devices Market Size Estimation and Forecast by Patient
13.10 MEA Infertility Drugs & Devices Market Size Estimation and Forecast by End-use
13.11 South Africa
13.11.1 South Africa Infertility Drugs & Devices Market by Product
13.12 GCC
13.12.1 GCC Infertility Drugs & Devices Market by Product
13.13 Rest of MEA
13.13.1 Rest of MEA Infertility Drugs & Devices Market by Product
14 Competitive Landscape
14.1 Company Ranking Analysis
14.2 Key Business Strategy Analysis
15 Company Profiles
15.1 The Cooper Companies, Inc.
15.1.1 Company Snapshot
15.1.2 Company Overview
15.1.3 Financial Analysis
15.1.4 Product Benchmarking
15.1.5 Strategic Outlook
15.1.6 SWOT Analysis
15.2 Vitrolife
15.2.1 Company Snapshot
15.2.2 Company Overview
15.2.3 Financial Analysis
15.2.4 Product Benchmarking
15.2.5 Strategic Outlook
15.3 Thermo Fisher Scientific
15.3.1 Company Snapshot
15.3.2 Company Overview
15.3.3 Financial Analysis
15.3.4 Product Benchmarking
15.3.5 Strategic Outlook
15.4 Hamilton Thorne
15.4.1 Company Snapshot
15.4.2 Company Overview
15.4.3 Financial Analysis
15.4.4 Product Benchmarking
15.4.5 Strategic Outlook
15.5 Esco Micro Pte Ltd
15.5.1 Company Snapshot
15.5.2 Company Overview
15.5.3 Product Benchmarking
15.5.4 Strategic Outlook
15.6 FUJIFILM Irvine Scientific
15.6.1 Company Snapshot
15.6.2 Company Overview
15.6.3 Financial Analysis
15.6.4 Product Benchmarking
15.6.5 Strategic Outlook
15.6.6 SWOT Analysis
15.7 The Baker Company
15.7.1 Company Snapshot
15.7.2 Company Overview
15.7.3 Product Benchmarking
15.7.4 Strategic Outlook
15.8 Merck KGaA
15.8.1 Company Snapshot
15.8.2 Company Overview
15.8.3 Financial Analysis
15.8.4 Product Benchmarking
15.8.5 Strategic Outlook
15.9 Ferring BV
15.9.1 Company Snapshot
15.9.2 Company Overview
15.9.3 Product Benchmarking
15.9.4 Strategic Outlook
15.9.5 SWOT Analysis
15.10 Abbott
15.10.1 Company Snapshot
15.10.2 Company Overview
15.10.3 Financial Analysis
15.10.4 Product Benchmarking
16 Conclusion and Recommendations
16.1 Concluding Remarks
16.2 Recommendations for Market Players
List of Tables
Table 1 Infertility Drugs & Devices Market Snapshot, 2024 & 2034 (US$ million, CAGR %)
Table 2 Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 3 Drugs Market, by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 4 Drugs Market, by Type, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 5 Gonadotropin Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 6 Aromatase Inhibitors Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 7 Selective Estrogen Receptor Modulators Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 8 Dopamine Agonists Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 9 Other Drug Classes Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 10 Equipment Market, by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 11 Equipment Market, By Type, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 12 Microscopes Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 13 Imaging Systems Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 14 Sperm Analyzer Systems Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 15 Ovum Aspiration Pumps Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 16 Micromanipulator Systems Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 17 Incubators Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 18 Gas Analyzers Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 19 Laser Systems Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 20 Cryosystems Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 21 Sperm Separation Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 22 Media & Consumables Market, by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 23 Accessories Market, by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 24 Infertility Drugs & Devices Procedure Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 25 Assisted Reproductive Technology Market, by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 26 Assisted Reproductive Technology Market, By Type, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 27 IVF Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 28 Intracytoplasmic Sperm Injection Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 29 Surrogacy Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 30 Artificial Insemination Market, by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 31 Artificial Insemination Market, By Type, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 32 Intrauterine Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 33 Intracervical Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 34 Intratubal Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 35 Fertility Surgeries Market, by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 36 Fertility Surgeries Market, By Type, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 37 Laparoscopy Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 38 Hysteroscopy Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 39 Varicocelectomy Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 40 Laparotomy Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 41 Tubal Ligation Reversal Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 42 Microsurgical Reconstruction Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 43 Other Infertility Treatment Procedures Market, by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 44 Infertility Drugs & Devices Patient Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 45 Female Market, by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 46 Male Market, by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 47 Infertility Drugs & Devices End Use Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 48 Fertility Centers Market, by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 49 Hospitals & Surgical Clinics Market, by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 50 Cryobanks Market, by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 51 Research Institutes Market, by Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 52 Infertility Drugs & Devices Market, By Region, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 53 North America Infertility Drugs & Devices Market, By Country, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 54 North America Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 55 North America Infertility Drugs Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 56 North America Infertility Equipment Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 57 North America Infertility Drugs & Devices Procedure Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 58 North America Patient Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 59 North America Infertility Drugs & Devices End Users Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 60 U.S. Infertility Drugs & Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 61 U.S. Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 62 Canada Infertility Drugs & Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 63 Canada Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 64 Europe Infertility Drugs & Devices Market, By Country, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 65 Europe Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 66 Europe Infertility Drugs Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 67 Europe Infertility Equipment Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 68 Europe Infertility Drugs & Devices Procedure Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 69 Europe Patient Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 70 Europe Infertility Drugs & Devices End-use Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 71 Germany Infertility Drugs & Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 72 Germany Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 73 UK Infertility Drugs & Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 74 UK Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 75 France Infertility Drugs & Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 76 France Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 77 Italy Infertility Drugs & Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 78 Italy Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 79 Spain Infertility Drugs & Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 80 Spain Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 81 Rest of Europe Infertility Drugs & Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 82 Rest of Europe Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 83 Asia Pacific Infertility Drugs & Devices Market, By Country, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 84 Asia Pacific Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 85 Asia-Pacific Infertility Drugs Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 86 Asia-Pacific Infertility Equipment Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 87 Asia-Pacific Infertility Drugs & Devices Procedure Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 88 Asia-Pacific Patient Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 89 Asia-Pacific Infertility Drugs & Devices End-use Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 90 Japan Infertility Drugs & Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 91 Japan Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 92 China Infertility Drugs & Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 93 China Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 94 India Infertility Drugs & Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 95 India Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 96 South Korea Infertility Drugs & Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 97 South Korea Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 98 Australia Infertility Drugs & Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 99 Australia Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 100 Rest of Asia Pacific Infertility Drugs & Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 101 Rest of Asia Pacific Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 102 Latin America Infertility Drugs & Devices Market, By Country, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 103 Latin America Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 104 Latin America Infertility Drugs Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 105 Latin America Infertility Equipment Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 106 Latin America Infertility Drugs & Devices Procedure Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 107 Latin America Patient Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 108 Latin America Infertility Drugs & Devices End-use Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 109 Brazil Infertility Drugs & Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 110 Brazil Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 111 Mexico Infertility Drugs & Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 112 Mexico Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 113 Rest of Latin America Infertility Drugs & Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 114 Rest of LATAM Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 115 MEA Infertility Drugs & Devices Market, By Country, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 116 MEA Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 117 MEA Infertility Drugs Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 118 MEA Infertility Equipment Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 119 MEA Infertility Drugs & Devices Procedure Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 120 MEA Patient Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 121 MEA Infertility Drugs & Devices End-use Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 122 South Africa Infertility Drugs & Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 123 South Africa Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 124 GCC Infertility Drugs & Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 125 GCC Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 126 Rest of MEA Infertility Drugs & Devices Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 127 Rest of MEA Infertility Drugs & Devices Product Market, 2024-2034 (US$ Mn, AGR (%), CAGR (%))
Table 128 Key Business Strategies Adopted by Key Players in Infertility Drugs & Devices Market Details
Table 129 The Cooper Companies, Inc. : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 130 The Cooper Companies, Inc. : Product Benchmarking
Table 131 The Cooper Companies, Inc. : Company Recent Developments
Table 132 Vitrolife: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 133 Vitrolife: Product Benchmarking
Table 134 Vitrolife : Company Recent Developments
Table 135 Thermo Fisher Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 136 Thermo Fisher Scientific: Product Benchmarking
Table 137 Thermo Fisher Scientific : Company Recent Developments
Table 138 Hamilton Thorne: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 139 Hamilton Thorne: Product Benchmarking
Table 140 Hamilton Thorne: Company Recent Developments
Table 141 Esco Micro Pte Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 142 Esco Micro Pte Ltd: Product Benchmarking
Table 143 Esco Micro Pte Ltd: Company Recent Developments
Table 144 FUJIFILM Irvine Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 145 FUJIFILM Irvine Scientific: Product Benchmarking
Table 146 FUJIFILM Irvine Scientific: Company Recent Developments
Table 147 The Baker Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 148 The Baker Company: Product Benchmarking
Table 149 The Baker Company: Company Recent Developments
Table 150 Merck KGaA : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 151 Merck KGaA : Product Benchmarking
Table 152 Merck KGaA : Company Recent Developments
Table 153 Ferring BV: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 154 Ferring BV: Product Benchmarking
Table 155 Ferring BV: Company Recent Developments
Table 156 Abbott : Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment)
Table 157 Abbott : Product Benchmarking
List of Figures
Figure 1 Infertility Drugs & Devices Market Segmentation
Figure 2 Infertility Drugs & Devices Market Forecast by Region: Market Attractiveness Index
Figure 3 Infertility Drugs & Devices Market by Product: Market Attractiveness Index
Figure 4 Infertility Drugs & Devices Market by Procedure: Market Attractiveness Index
Figure 5 Infertility Drugs & Devices Market by Patient: Market Attractiveness Index
Figure 6 Infertility Drugs & Devices Market by End-use: Market Attractiveness Index
Figure 1 Infertility Drugs & Devices Market: Market Dynamics
Figure 7 Infertility Drugs & Devices Market: Impact Analysis
Figure 8 Infertility Drugs & Devices Market: Supply Chain Analysis
Figure 2 Infertility Drugs & Devices Market: Porter’s Five Forces Analysis
Figure 3 Infertility Drugs & Devices Market: PEST Analysis
Figure 4 Infertility Drugs & Devices Market Forecast by Product 2024 (Revenue, CAGR%)
Figure 5 Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
Figure 6 Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 7 Drugs Market Forecast by Region, 2024-2034 (US$ million)
Figure 8 Drugs Market Share Forecast by Region, 2024 and 2034 (%)
Figure 9 Drugs Market Forecast by Type, 2024-2034 (US$ million)
Figure 10 Drugs Market Share Forecast by Type, 2024 and 2034 (%)
Figure 11 Gonadotropins Market Forecast, 2024-2034 (US$ million)
Figure 12 Aromatase Inhibitors Market Forecast, 2024-2034 (US$ million)
Figure 13 Selective Estrogen Receptor Modulators (SERMs) Market Forecast, 2024-2034 (US$ million)
Figure 14 Dopamine Agonists Market Forecast, 2024-2034 (US$ million)
Figure 15 Other Drug Classes Market Forecast by Region, 2024-2034 (US$ million)
Figure 16 Equipment Market Forecast by Region, 2024-2034 (US$ million)
Figure 17 Equipment Market Share Forecast by Region, 2024 and 2034 (%)
Figure 18 Equipment Market Forecast by Type, 2024-2034 (US$ million)
Figure 19 Equipment Market Share Forecast by Type, 2024 and 2034 (%)
Figure 20 Microscopes Market Forecast, 2024-2034 (US$ million)
Figure 21 Imaging Systems Market Forecast, 2024-2034 (US$ million)
Figure 22 Sperm Analyzer Systems Market Forecast, 2024-2034 (US$ million)
Figure 23 Ovum Aspiration Pumps Market Forecast, 2024-2034 (US$ million)
Figure 24 Micromanipulator Systems Market Forecast, 2024-2034 (US$ million)
Figure 25 Incubators Market Forecast, 2024-2034 (US$ million)
Figure 26 Gas Analyzers Market Forecast, 2024-2034 (US$ million)
Figure 27 Laser Systems Market Forecast, 2024-2034 (US$ million)
Figure 28 Cryosystems Market Forecast, 2024-2034 (US$ million)
Figure 29 Sperm Separation Devices Market Forecast, 2024-2034 (US$ million)
Figure 30 Media & Consumables Market Forecast by Region, 2024-2034 (US$ million)
Figure 31 Media & Consumables Market Share Forecast by Region, 2024 and 2034 (%)
Figure 32 Accessories Market Forecast by Region, 2024-2034 (US$ million)
Figure 33 Accessories Market Share Forecast by Region, 2024-2034 (%)
Figure 34 Infertility Drugs & Devices Market Forecast by Procedure 2024 (Revenue, CAGR%)
Figure 35 Infertility Drugs & Devices Market Forecast by Procedure, 2024-2034 (US$ Million, AGR %)
Figure 36 Infertility Drugs & Devices Market Share Forecast by Procedure, 2024 and 2034 (%)
Figure 37 Assisted Reproductive Technology Market Forecast by Region, 2024-2034 (US$ million)
Figure 38 Assisted Reproductive Technology Market Share Forecast by Region, 2024 and 2034 (%)
Figure 39 Assisted Reproductive Technology Market Forecast by Type, 2024-2034 (US$ million)
Figure 40 Assisted Reproductive Technology Market Share Forecast by Type, 2024 and 2034 (%)
Figure 41 IVF Market Forecast, 2024-2034 (US$ million)
Figure 42 Intracytoplasmic Sperm Injection Market Forecast, 2024-2034 (US$ million)
Figure 43 Surrogacy Market Forecast, 2024-2034 (US$ million)
Figure 44 Artificial Insemination Market Forecast by Region, 2024-2034 (US$ million)
Figure 45 Artificial Insemination Market Share Forecast by Region, 2024 and 2034 (%)
Figure 46 Artificial Insemination Market Forecast by Type, 2024-2034 (US$ million)
Figure 47 Artificial Insemination Market Share Forecast by Type, 2024 and 2034 (%)
Figure 48 Intrauterine Market Forecast, 2024-2034 (US$ million)
Figure 49 Intracervical Market Forecast, 2024-2034 (US$ million)
Figure 50 Intratubal Market Forecast, 2024-2034 (US$ million)
Figure 51 Fertility Surgeries Market Forecast by Region, 2024-2034 (US$ million)
Figure 52 Fertility Surgeries Market Share Forecast by Region, 2024 and 2034 (%)
Figure 53 Fertility Surgeries Market Forecast by Type, 2024-2034 (US$ million)
Figure 54 Fertility Surgeries Market Share Forecast by Type, 2024 and 2034 (%)
Figure 55 Laparoscopy Market Forecast, 2024-2034 (US$ million)
Figure 56 Hysteroscopy Market Forecast, 2024-2034 (US$ million)
Figure 57 Varicocelectomy Market Forecast, 2024-2034 (US$ million)
Figure 58 Laparotomy Market Forecast, 2024-2034 (US$ million)
Figure 59 Tubal Ligation Reversal Market Forecast, 2024-2034 (US$ million)
Figure 60 Microsurgical Reconstruction Market Forecast, 2024-2034 (US$ million)
Figure 61 Other Infertility Treatment Procedures Market Forecast by Region, 2024-2034 (US$ million)
Figure 62 Other Infertility Treatment Procedures Market Share Forecast by Region, 2024 and 2034 (%)
Figure 63 Infertility Drugs & Devices Market Forecast by Patient 2024 (Revenue, CAGR%)
Figure 64 Infertility Drugs & Devices Market Forecast by Patient, 2024-2034 (US$ Million, AGR %)
Figure 65 Infertility Drugs & Devices Market Share Forecast by Patient, 2024, 2029, 2034 (%)
Figure 66 Female Market Forecast by Region, 2024-2034 (US$ million)
Figure 67 Female Market Share Forecast by Region, 2024 and 2034 (%)
Figure 68 Male Market Forecast by Region, 2024-2034 (US$ million)
Figure 69 Male Market Share Forecast by Region, 2024 and 2034 (%)
Figure 70 Infertility Drugs & Devices Market Forecast by End-use 2024 (Revenue, CAGR%)
Figure 71 Infertility Drugs & Devices Market Forecast by End-use, 2024-2034 (US$ Million, AGR %)
Figure 72 Infertility Drugs & Devices Market Share Forecast by End-use, 2024, 2029, 2034 (%)
Figure 73 Fertility Centers Market Forecast by Region, 2024-2034 (US$ million)
Figure 74 Fertility Centers Market Share Forecast by Region, 2024 and 2034 (%)
Figure 75 Hospitals & Surgical Clinics Market Forecast by Region, 2024-2034 (US$ million)
Figure 76 Hospitals & Surgical Clinics Market Share Forecast by Region, 2024 and 2034 (%)
Figure 77 Cryobanks Market Forecast by Region, 2024-2034 (US$ million)
Figure 78 Cryobanks Market Share Forecast by Region, 2024 and 2034 (%)
Figure 79 Research Institutes Market Forecast by Region, 2024-2034 (US$ million)
Figure 80 Research Institutes Market Share Forecast by Region, 2024 and 2034 (%)
Figure 81 Infertility Drugs & Devices Market Forecast by Region 2024, 2034 (Revenue)
Figure 82 Infertility Drugs & Devices Market Share Forecast by Region 2024, 2029, 2034 (%)
Figure 83 Infertility Drugs & Devices Market by Region, 2024-2034 (US$ Million, AGR %, CAGR %)
Figure 84 North America Infertility Drugs & Devices Market Attractiveness Index, 2024
Figure 85 North America Infertility Drugs & Devices Market by Region, 2024, 2029 & 2034 (US$ million)
Figure 86 North America Infertility Drugs & Devices Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
Figure 87 North America Infertility Drugs & Devices Market Share Forecast by Country, 2024, 2029, 2034(%)
Figure 88 North America Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 89 North America Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
Figure 90 North America Infertility Drugs & Devices Market Forecast by Drugs, 2024-2034 (US$ Million, AGR %)
Figure 91 North America Infertility Drugs & Devices Market Share Forecast by Drugs, 2024, 2029, 2034 (%)
Figure 92 North America Infertility Drugs & Devices Market Forecast by Equipment, 2024-2034 (US$ Million, AGR %)
Figure 93 North America Infertility Drugs & Devices Market Share Forecast by Equipment, 2024, 2029, 2034 (%)
Figure 94 North America Infertility Drugs & Devices Market Forecast by Procedure, 2024-2034 (US$ Million, AGR %)
Figure 95 North America Infertility Drugs & Devices Market Share Forecast by Procedure, 2024, 2029, 2034 (%)
Figure 96 North America Infertility Drugs & Devices Market Forecast by Patient, 2024-2034 (US$ Million, AGR %)
Figure 97 North America Infertility Drugs & Devices Market Share Forecast by Patient, 2024, 2029, 2034 (%)
Figure 98 North America Infertility Drugs & Devices Market Forecast by End-use, 2024-2034 (US$ Million, AGR %)
Figure 99 North America Infertility Drugs & Devices Market Share Forecast by End-use, 2024, 2029, 2034 (%)
Figure 100 U.S. Infertility Drugs & Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 101 U.S. Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 102 U.S. Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
Figure 103 Canada Infertility Drugs & Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 104 Canada Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 105 Canada Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
Figure 106 Europe Infertility Drugs & Devices Market Attractiveness Index, 2024
Figure 107 Europe Infertility Drugs & Devices Market by Country, 2024, 2029 & 2034 (US$ million)
Figure 108 Europe Infertility Drugs & Devices Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
Figure 109 Europe Infertility Drugs & Devices Market Share Forecast by Country, 2024, 2029, 2034 (%)
Figure 110 Europe Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 111 Europe Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
Figure 112 Europe Infertility Drugs & Devices Market Forecast by Drugs, 2024-2034 (US$ Million, AGR %)
Figure 113 Europe Infertility Drugs & Devices Market Share Forecast by Drugs, 2024, 2029, 2034 (%)
Figure 114 Europe Infertility Drugs & Devices Market Forecast by Equipment, 2024-2034 (US$ Million, AGR %)
Figure 115 Europe Infertility Drugs & Devices Market Share Forecast by Equipment, 2024, 2029, 2034 (%)
Figure 116 Europe Infertility Drugs & Devices Market Forecast by Procedure, 2024-2034 (US$ Million, AGR %)
Figure 117 Europe Infertility Drugs & Devices Market Share Forecast by Procedure, 2024, 2029, 2034 (%)
Figure 118 Europe Infertility Drugs & Devices Market Forecast by Patient, 2024-2034 (US$ Million, AGR %)
Figure 119 Europe Infertility Drugs & Devices Market Share Forecast by Patient, 2024, 2029, 2034 (%)
Figure 120 Europe Infertility Drugs & Devices Market Forecast by End-use, 2024-2034 (US$ Million, AGR %)
Figure 121 Europe Infertility Drugs & Devices Market Share Forecast by End-use, 2024, 2029, 2034 (%)
Figure 122 Germany Infertility Drugs & Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 123 Germany Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 124 Germany Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
Figure 125 U.K. Infertility Drugs & Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 126 U.K. Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 127 U.K. Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
Figure 128 France Infertility Drugs & Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 129 France Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 130 France Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
Figure 131 Italy Infertility Drugs & Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 132 Italy Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 133 Italy Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
Figure 134 Spain Infertility Drugs & Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 135 Spain Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 136 Spain Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
Figure 137 Rest of Europe Infertility Drugs & Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 138 Rest of Europe Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 139 Rest of Europe Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
Figure 140 Asia Pacific Infertility Drugs & Devices Market Attractiveness Index, 2024
Figure 141 Asia Pacific Infertility Drugs & Devices Market by Country, 2024, 2029 & 2034 (US$ million)
Figure 142 Asia Pacific Infertility Drugs & Devices Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
Figure 143 Asia Pacific Infertility Drugs & Devices Market Share Forecast by Country, 2024, 2029, 2034 (%)
Figure 144 Asia Pacific Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 145 Asia Pacific Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
Figure 146 Asia Pacific Infertility Drugs & Devices Market Forecast by Drugs, 2024-2034 (US$ Million, AGR %)
Figure 147 Asia Pacific Infertility Drugs & Devices Market Share Forecast by Drugs, 2024, 2029, 2034 (%)
Figure 148 Asia Pacific Infertility Drugs & Devices Market Forecast by Equipment, 2024-2034 (US$ Million, AGR %)
Figure 149 Asia Pacific Infertility Drugs & Devices Market Share Forecast by Equipment, 2024, 2029, 2034 (%)
Figure 150 Asia-Pacific Infertility Drugs & Devices Market Forecast by Procedure, 2024-2034 (US$ Million, AGR %)
Figure 151 Asia-Pacific Infertility Drugs & Devices Market Share Forecast by Procedure, 2024, 2029, 2034 (%)
Figure 152 Asia Pacific Infertility Drugs & Devices Market Forecast by Patient, 2024-2034 (US$ Million, AGR %)
Figure 153 Asia Pacific Infertility Drugs & Devices Market Share Forecast by Patient, 2024, 2029, 2034 (%)
Figure 154 Asia Pacific Infertility Drugs & Devices Market Forecast by End-use, 2024-2034 (US$ Million, AGR %)
Figure 155 Asia Pacific Infertility Drugs & Devices Market Share Forecast by End-use, 2024, 2029, 2034 (%)
Figure 156 Japan Infertility Drugs & Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 157 Japan Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 158 Japan Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
Figure 159 China Infertility Drugs & Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 160 China Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 161 China Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
Figure 162 India Infertility Drugs & Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 163 India Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 164 India Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
Figure 165 South Korea Infertility Drugs & Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 166 South Korea Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 167 South Korea Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
Figure 168 Australia Infertility Drugs & Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 169 Australia Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 170 Australia Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
Figure 171 Rest of Asia Pacific Infertility Drugs & Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 172 Rest of APAC Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 173 Rest of APAC Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
Figure 174 Latin America Infertility Drugs & Devices Market Attractiveness Index, 2024
Figure 175 Latin America Infertility Drugs & Devices Market by Country, 2024, 2029 & 2034 (US$ million)
Figure 176 Latin America Infertility Drugs & Devices Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
Figure 177 Latin America Infertility Drugs & Devices Market Share Forecast by Country, 2024, 2029, 2034 (%)
Figure 178 Latin America Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 179 Latin America Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
Figure 180 Latin America Infertility Drugs & Devices Market Forecast by Drugs, 2024-2034 (US$ Million, AGR %)
Figure 181 Latin America Infertility Drugs & Devices Market Share Forecast by Drugs, 2024, 2029, 2034 (%)
Figure 182 Latin America Infertility Drugs & Devices Market Forecast by Equipment, 2024-2034 (US$ Million, AGR %)
Figure 183 Latin America Infertility Drugs & Devices Market Share Forecast by Equipment, 2024, 2029, 2034 (%)
Figure 184 Latin America Infertility Drugs & Devices Market Forecast by Procedure, 2024-2034 (US$ Million, AGR %)
Figure 185 Latin America Infertility Drugs & Devices Market Share Forecast by Procedure, 2024, 2029, 2034 (%)
Figure 186 Latin America Infertility Drugs & Devices Market Forecast by Patient, 2024-2034 (US$ Million, AGR %)
Figure 187 Latin America Infertility Drugs & Devices Market Share Forecast by Patient, 2024, 2029, 2034 (%)
Figure 188 Latin America Infertility Drugs & Devices Market Forecast by End-use, 2024-2034 (US$ Million, AGR %)
Figure 189 Latin America Infertility Drugs & Devices Market Share Forecast by End-use, 2024, 2029, 2034 (%)
Figure 190 Brazil Infertility Drugs & Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 191 Brazil Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 192 Brazil Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
Figure 193 Mexico Infertility Drugs & Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 194 Mexico Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 195 Mexico Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
Figure 196 Rest of LATAM Infertility Drugs & Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 197 Rest of LATAM Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 198 Rest of LATAM Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
Figure 199 MEA Infertility Drugs & Devices Market Attractiveness Index, 2024
Figure 200 MEA Infertility Drugs & Devices Market by Country, 2024, 2029 & 2034 (US$ million)
Figure 201 MEA Infertility Drugs & Devices Market Forecast by Country, 2024-2034 (US$ Million, AGR %)
Figure 202 MEA Infertility Drugs & Devices Market Share Forecast by Country, 2024, 2029, 2034 (%)
Figure 203 MEA Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 204 MEA Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
Figure 205 MEA Infertility Drugs & Devices Market Forecast by Drugs, 2024-2034 (US$ Million, AGR %)
Figure 206 MEA Infertility Drugs & Devices Market Share Forecast by Drugs, 2024, 2029, 2034 (%)
Figure 207 MEA Infertility Drugs & Devices Market Forecast by Equipment, 2024-2034 (US$ Million, AGR %)
Figure 208 MEA Infertility Drugs & Devices Market Share Forecast by Equipment, 2024, 2029, 2034 (%)
Figure 209 MEA Infertility Drugs & Devices Market Forecast by Procedure, 2024-2034 (US$ Million, AGR %)
Figure 210 MEA Infertility Drugs & Devices Market Share Forecast by Procedure, 2024, 2029, 2034 (%)
Figure 211 MEA Infertility Drugs & Devices Market Forecast by Patient, 2024-2034 (US$ Million, AGR %)
Figure 212 MEA Infertility Drugs & Devices Market Share Forecast by Patient, 2024, 2029, 2034 (%)
Figure 213 MEA Infertility Drugs & Devices Market Forecast by End-use, 2024-2034 (US$ Million, AGR %)
Figure 214 MEA Infertility Drugs & Devices Market Share Forecast by End-use, 2024, 2029, 2034 (%)
Figure 215 South Africa Infertility Drugs & Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 216 South Africa Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 217 South Africa Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
Figure 218 GCC Infertility Drugs & Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 219 GCC Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 220 GCC Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
Figure 221 Rest of MEA Infertility Drugs & Devices Market Forecast, 2024-2034 (US$ Million, AGR %)
Figure 222 Rest of MEA Infertility Drugs & Devices Market Forecast by Product, 2024-2034 (US$ Million, AGR %)
Figure 223 Rest of MEA Infertility Drugs & Devices Market Share Forecast by Product, 2024, 2029, 2034 (%)
Figure 224 Infertility Drugs & Devices Market: Company Ranking Analysis, 2023
Figure 225 The Cooper Companies, Inc. : Net Sales, 2019-2023 (US$ Million, AGR %)
Figure 226 The Cooper Companies, Inc. : Regional Market Shares, 2023
Figure 227 The Cooper Companies, Inc. : R&D, 2019-2023 (US$ Million, AGR %)
Figure 9 The Cooper Companies, Inc: SWOT Analysis
Figure 228 Vitrolife Group : Net Sales, 2019-2023 (US$ Million, AGR %)
Figure 229 Vitrolife Group : Regional Market Shares, 2023
Figure 230 Vitrolife Group : R&D, 2019-2023 (US$ Million, AGR %)
Figure 231 Thermo Fisher Scientific: Net Revenue, 2019-2023 (US$ Billion, AGR %)
Figure 232 Thermo Fisher Scientific: Regional Market Shares, 2023
Figure 233 Thermo Fisher Scientific: R&D, 2019-2023 (US$ Billion, AGR %)
Figure 234 Hamilton Thorne: Net Sales, 2019-2023 (US$ Million, AGR %)
Figure 235 Hamilton Thorne: Regional Market Shares, 2023
Figure 236 Hamilton Thorne: R&D, 2019-2023 (US$ Million, AGR %)
Figure 237 FUJIFILM: Revenue, 2019-2023 (US$ Billion, AGR %)
Figure 238 FUJIFILM: Regional Market Shares, 2023
Figure 239 FUJIFILM: R&D, 2019-2023 (US$ Billion, AGR %)
Figure 10 FUJIFILM Irvine Scientific: SWOT Analysis
Figure 240 Merck KGaA : Net Revenue, 2019-2023 (US$ Million, AGR %)
Figure 241 Merck KGaA : Regional Market Shares, 2023
Figure 242 Merck KGaA: R&D, 2019-2023 (US$ Million, AGR %)
Figure 11 Ferring BV: SWOT Analysis
Figure 243 Abbott : Net Revenue, 2019-2023 (US$ Million, AGR %)
Figure 244 Abbott : Regional Market Shares, 2023
Figure 245 Abbott : R&D, 2019-2023 (US$ Million, AGR %)

Companies Mentioned

  • Abbott Laboratories
  • Esco Micro Pte Ltd
  • Ferring BV
  • FUJIFILM Irvine Scientific
  • Hamilton Thorne
  • Merck KGaA
  • The Baker Company
  • The Cooper Companies, Inc.
  • Thermo Fisher Scientific
  • Vitrolife
  • BioInnovation
  • Cook Medical
  • eFertility
  • Evidence Solution
  • Generate Life Sciences
  • Igenomix S.L.
  • Illumina
  • Lab Central
  • Life Whisperer Genetics
  • Obp Medical Corporation
  • Royal Philips
  • Safe Obstetric Systems 
  • National Institute for Health and Care Excellence (NICE) [U.K.]
  • National Institute of Allergy and Infectious Diseases (NIAID) [U.S.]
  • National Institutes of Health [U.S.]
  • European Medicines Agency (EMA)
  • European Pharmaceutical Market Research Association (EPhMRA)
  • Food and Drug Administration (FDA) [U.S.]
  • Health Canada
  • National Development and Reform Commission (NDRC) [China]
  • National Health Services (NHS) [U.K.]
  • National Pharmaceutical Pricing Authority (NPPA) [China]
  • Pharmaceuticals and Medical Devices Agency (PMDA) [Japan]
  • Servicio Sanitario Nazionale (SSN) [U.S.]
  • U.K. Medicines and Healthcare Products Regulatory Agency (MHRA)
  • U.S. Patent Office
  • World Health Organization (WHO)